A BILL 
To amend title III of the Public Health Service Act with 
respect to the determination by the Secretary regarding 
certain biosimilar application elements, and for other 
purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Lowering Costs by Im-
4
proving Biosimilar Uptake Act’’. 
5
18:49 Mar 15, 2022
H7047
2 
•HR 7047 IH
SEC. 2. DETERMINATION BY SECRETARY REGARDING CER-
1
TAIN BIOSIMILAR APPLICATION ELEMENTS. 
2
Section 351(k)(2)(A)(ii) of the Public Health Service 
3
Act (262(k)(2)(A)(ii)) is amended to read as follows: 
4
‘‘(ii) DETERMINATION BY SECRETARY 
5
REGARDING
CERTAIN
APPLICATION
ELE-
6
MENTS.— 
7
‘‘(I) IN
GENERAL.—The Sec-
8
retary may determine, in the Sec-
9
retary’s discretion, that an element 
10
described in clause (i)(I), or in clause 
11
(i)(IV) with respect to the strength of 
12
a biological product, is unnecessary in 
13
an application submitted under this 
14
subsection. 
15
‘‘(II) USE OF DETERMINATION.— 
16
If the Secretary makes a determina-
17
tion under this clause that informa-
18
tion demonstrating that the strength 
19
of the biological product is the same 
20
as that of the reference product as de-
21
scribed in clause (i)(IV) is unneces-
22
sary, the term ‘reference product’ 
23
shall, for purposes of this section with 
24
respect to such biological product, in-
25
18:49 Mar 15, 2022
H7047
3 
•HR 7047 IH
clude all applicable strengths of the 
1
reference product.’’. 
2
Æ 
18:49 Mar 15, 2022
H7047
